Zhi-Bin Zeng

Zhi-Bin Zeng

Auto-generated profile, based on publicly available information

Zhi-Bin Zeng

Radiology Department, Huazhong University of Science and Technology Union Shenzhen Hospital

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 April 2024 in medRxiv
Verified
Preprint
Open access
PDF file
GLGen Li
Gen Li
DXDi-Hao Xu
Di-Hao Xu
JXJing-Wen Xie
Jing-Wen Xie
LMLi-Ping Ma
Li-Ping Ma
MSMin Shu
Min Shu
ZZZhi-Bin Zeng
Zhi-Bin Zeng
Objective: This study aimed to delineate the differences in plaques characteristics between positive remodeling (PR) and non-positive remodeling (NPR) in patients with Acute ischemia stroke (AIS), and to assess the associated relative risk factors for PR in intracranial atherosclerosis (ICAS). Methods: Patients with AIS were enrolled and underwent high-resolution magnetic resonance vessel wall imaging (HR-VWI) within two weeks of symptom onset. We compared plaque morphologies and clinical variables between the PR and NPR cohorts. Binary logistic regression was employed to isolate independent predictors of PR, and the predictive model’s sensitivity and specificity were gauged using the receiver operating characteristic curve. Results: A total of 84 patients (mean age 58.07±1.35 years, 78.6% male) were categorized into PR (n=28, 33.3%) or NPR (n=56, 66.4%) groups based on the remodeling index (RI). The PR group exhibited a significantly higher percent plaque burden (P<0.001), wall area (WA) (P<0.001), plaque length (P=0.018), and RI (P<0.001), alongside elevated fasting blood glucose (P=0.01) and a higher prevalence of hypertension and diabetes mellitus (P=0.16, 0.025). Logistic regression analysis identified percent plaque burden as an independent predictor of PR (odds ratio, 4.19, per 10% increase; [95% CI, 1.79-9.8]; P =0.001). Conclusion: HR-VWI is an effective tool for identifying PR in AIS caused by ICAS, with a high plaque burden being an independent correlate of PR.

13 October 2022 in Disease Markers
Verified
Journal Article
Open access
PDF file
LMLi-Ping Ma
Li-Ping Ma
CSCui-Yun Sheng
Cui-Yun Sheng
LQLong Qian
Long Qian
ZZZhi-Bin Zeng
Zhi-Bin Zeng
GLGen Li
Gen Li
Objective. To investigate the feasibility and correlation of sacroiliac joint (SIJ) fat fraction (FF) and R2 ∗ as markers of bone metabolism in patients with ankylosing spondylitis (AS). Methods. 75 AS patients were classified into an early active group (EA), late active group (LA), and inactive group (IA). Additionally, 54 matched healthy individuals were selected to be part of the normal control group (NC). All participants underwent chemical shift encoded based MRI (IDEAL-IQ) and routine clinical SIJ MRI at 3.0 T. FF and R2 ∗ were measured in subchondral bone, bone marrow edema (BME), and fat metaplasia (FM). Out of the participants, 39 with BME lesions (15 from EA, 16 from LA, 8 from IA) and 39 with FM lesions (9 from EA, 17 from LA, 13 from IA) were included. Differences in FF, R2 ∗ value for subchondral bone of all participants and for BME, FM lesions were evaluated. Subsequently, different stages of BME and FM in patient groups were compared, and the relationship between FF and R2 ∗ was analyzed. Results. A significant difference in FF was demonstrated among the BME, FM and the normal bone marrow ( p < 0.001 ), meanwhile, the difference of R2 ∗ value in FM was significantly lower ( p = 0.034 , 0.012) than that of BME and that of normal bone marrow. At lever of different lesions, only the FF for BME was significantly different among 3 patient groups ( p = 0.001 ), while there was no significantly different FF for FM among 3 patient groups. Unlike in BME lesions, the FF in FM lesions had a negative correlation with R2 ∗ ( p < 0.001 , r = − 0.488 ). Conclusion. FF and R2 ∗ measurements help to quantitatively analyze the bone marrow fat composition and bony trabecular microstructure changes in AS, providing a noninvasive and accurate assessment basis for AS bone metabolism abnormalities.